Research & Development
US FDA Launches Podcast Discussing COVID-19 Treatment Development Process
24 June 2020 - - The US Food and Drug Administration has launched the first "FDA Insight" podcast, featuring FDA Commissioner Stephen Hahn, M.D., and FDA Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D., discussing FDA's COVID-19 efforts, including the drug development process for a COVID-19 treatment, the agency said.

Future FDA Insight podcasts will feature Hahn, Shah, and other FDA leaders' insights into issues facing the agency, including the COVID-19 pandemic and other emerging topics.

FDA Commissioner Stephen Hahn, M.D., spoke at the German Marshall Fund's Brussels Forum 2020.

This 15th edition of the forum, live-streamed/posted on YouTube, featured a 25-minute conversation with Dr. Hahn, moderated by Axios Health Care Editor Sam Baker.

The FDA, an agency within the US Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Related Headlines